
    
      The Swiss Multiple Sclerosis Cohort (SMSC-Study) aims to better evaluate specific Multiple
      Sclerosis (MS) phenotypes through the systematic and standardised documentation and
      acquisition of clinical course and paraclinical tests such as magnetic resonance imaging
      (MRI), blood and cerebrospinal fluid (CSF) specimens.

      Determination of the relative contribution of SC metrics (cervical cord volume, cervical grey
      matter (GM) cord volume, cervical white matter (WM) cord volume, SC lesion load) to
      disability in MS.
    
  